Literature DB >> 26007164

Can lateral ventricle contact predict the ontogeny and prognosis of glioblastoma?

Sheng Han1, Xiang Li, Bo Qiu, Tao Jiang, Anhua Wu.   

Abstract

Lateral ventricle contact (LVC) by glioblastomas has been proposed to reveal their origin and may have prognostic value; however, results from previous studies have been controversial. This study explored the association between LVC and tumor origin and prognosis in glioblastoma patients. Magnetic resonance imaging and clinical data from 115 glioma patients were retrospectively reviewed, and Kaplan-Meier analysis and Cox proportional hazards models were used to assess the occurrence of LVC as a function of survival in 43 glioblastoma patients. The mRNA expression profiles were compared by microarray analysis in LV-contacting and non-LV-contacting glioblastomas (LVCGs and NLVCGs, respectively). The sphere-forming and invasive capabilities of LVCG- and NLVCG-derived stem cells were compared in primary glioma stem cell cultures with tumorsphere formation and Matrigel assays, respectively. LVC was more frequently detected in high-grade gliomas which, along with LVCGs, were significantly larger than low-grade gliomas and NLVCGs. LVC parameters were not independent predictors of glioblastoma patient prognosis; the expression profiles (including stemness genes expression) were similar between LVCGs and NLVCGs, and no significant differences were observed in tumorsphere-forming capacity and invasiveness between stem cells derived from the two glioblastoma types. Our results suggest that the origin of glioblastomas cannot be simply estimated by radiographic LVC, and after standard therapy the prognostic value of LVC needs to be carefully interpreted.

Entities:  

Mesh:

Year:  2015        PMID: 26007164     DOI: 10.1007/s11060-015-1818-x

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  25 in total

1.  Sample-size calculations for the Cox proportional hazards regression model with nonbinary covariates.

Authors:  F Y Hsieh; P W Lavori
Journal:  Control Clin Trials       Date:  2000-12

2.  Relationship of glioblastoma multiforme to the lateral ventricles predicts survival following tumor resection.

Authors:  Kaisorn L Chaichana; Matthew J McGirt; James Frazier; Frank Attenello; Hugo Guerrero-Cazares; Alfredo Quinones-Hinojosa
Journal:  J Neurooncol       Date:  2008-05-06       Impact factor: 4.130

3.  Interleukin-6 is overexpressed and augments invasiveness of human glioma stem cells in vitro.

Authors:  Bo Qiu; Dongyong Zhang; Yong Wang; Shaowu Ou; Jun Wang; Jun Tao; Yunjie Wang
Journal:  Clin Exp Metastasis       Date:  2013-07-06       Impact factor: 5.150

4.  Probabilistic radiographic atlas of glioblastoma phenotypes.

Authors:  B M Ellingson; A Lai; R J Harris; J M Selfridge; W H Yong; K Das; W B Pope; P L Nghiemphu; H V Vinters; L M Liau; P S Mischel; T F Cloughesy
Journal:  AJNR Am J Neuroradiol       Date:  2012-09-20       Impact factor: 3.825

5.  Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group.

Authors:  Wei Yan; Wei Zhang; Gan You; Junxia Zhang; Lei Han; Zhaoshi Bao; Yongzhi Wang; Yanwei Liu; Chuanlu Jiang; Chunsheng Kang; Yongping You; Tao Jiang
Journal:  Neuro Oncol       Date:  2012-10-22       Impact factor: 12.300

6.  Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens.

Authors:  Steven M Pollard; Koichi Yoshikawa; Ian D Clarke; Davide Danovi; Stefan Stricker; Roslin Russell; Jane Bayani; Renee Head; Marco Lee; Mark Bernstein; Jeremy A Squire; Austin Smith; Peter Dirks
Journal:  Cell Stem Cell       Date:  2009-06-05       Impact factor: 24.633

7.  Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

Authors:  Marc Sanson; Yannick Marie; Sophie Paris; Ahmed Idbaih; Julien Laffaire; François Ducray; Soufiane El Hallani; Blandine Boisselier; Karima Mokhtari; Khe Hoang-Xuan; Jean-Yves Delattre
Journal:  J Clin Oncol       Date:  2009-07-27       Impact factor: 44.544

8.  A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme.

Authors:  Kaisorn Chaichana; Scott Parker; Alessandro Olivi; Alfredo Quiñones-Hinojosa
Journal:  J Neurosurg       Date:  2010-05       Impact factor: 5.115

9.  Longitudinal MRI evidence for decreased survival among periventricular glioblastoma.

Authors:  Geoffrey S Young; Eric A Macklin; Kian Setayesh; Joshua D Lawson; Patrick Y Wen; Andrew D Norden; Jan Drappatz; Santosh Kesari
Journal:  J Neurooncol       Date:  2010-12-05       Impact factor: 4.130

10.  Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma.

Authors:  S Han; C Zhang; Q Li; J Dong; Y Liu; Y Huang; T Jiang; A Wu
Journal:  Br J Cancer       Date:  2014-04-01       Impact factor: 7.640

View more
  9 in total

1.  Decreased survival in glioblastomas is specific to contact with the ventricular-subventricular zone, not subgranular zone or corpus callosum.

Authors:  Akshitkumar M Mistry; Michael C Dewan; Gabrielle A White-Dzuro; Philip R Brinson; Kyle D Weaver; Reid C Thompson; Rebecca A Ihrie; Lola B Chambless
Journal:  J Neurooncol       Date:  2017-01-10       Impact factor: 4.130

Review 2.  Influence of glioblastoma contact with the lateral ventricle on survival: a meta-analysis.

Authors:  Akshitkumar M Mistry; Andrew T Hale; Lola B Chambless; Kyle D Weaver; Reid C Thompson; Rebecca A Ihrie
Journal:  J Neurooncol       Date:  2016-09-19       Impact factor: 4.130

3.  NFAT1-regulated IL6 signalling contributes to aggressive phenotypes of glioma.

Authors:  Yang Jiang; Sheng Han; Wen Cheng; Zixun Wang; Anhua Wu
Journal:  Cell Commun Signal       Date:  2017-12-19       Impact factor: 5.712

4.  Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling.

Authors:  Sheng Han; Lingxuan Meng; Yang Jiang; Wen Cheng; Xinxin Tie; Junzhe Xia; Anhua Wu
Journal:  Br J Cancer       Date:  2017-03-30       Impact factor: 7.640

5.  LPS alters the immuno-phenotype of glioma and glioma stem-like cells and induces in vivo antitumor immunity via TLR4.

Authors:  Sheng Han; Chao Wang; Xiaofei Qin; Junzhe Xia; Anhua Wu
Journal:  J Exp Clin Cancer Res       Date:  2017-06-22

6.  Ventricular-Subventricular Zone Contact by Glioblastoma is Not Associated with Molecular Signatures in Bulk Tumor Data.

Authors:  Akshitkumar M Mistry; David J Wooten; L Taylor Davis; Bret C Mobley; Vito Quaranta; Rebecca A Ihrie
Journal:  Sci Rep       Date:  2019-02-12       Impact factor: 4.379

7.  High dose vs low dose irradiation of the subventricular zone in patients with glioblastoma-a systematic review and meta-analysis.

Authors:  Sergiu Şuşman; Gabriel Kacso; Daniel-Corneliu Leucuţa; Ştefan Ioan Florian
Journal:  Cancer Manag Res       Date:  2019-07-18       Impact factor: 3.989

8.  Construction and validation of an angiogenesis-related gene expression signature associated with clinical outcome and tumor immune microenvironment in glioma.

Authors:  Tianhao Hu; Yutao Wang; Xiaoliang Wang; Run Wang; Yifu Song; Li Zhang; Sheng Han
Journal:  Front Genet       Date:  2022-08-11       Impact factor: 4.772

9.  MCM8 is regulated by EGFR signaling and promotes the growth of glioma stem cells through its interaction with DNA-replication-initiating factors.

Authors:  Xiaoliang Wang; Li Zhang; Yifu Song; Yang Jiang; Di Zhang; Run Wang; Tianhao Hu; Sheng Han
Journal:  Oncogene       Date:  2021-06-15       Impact factor: 9.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.